20233 ⎘
Medicinal preparations containing organic active ingredients; Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
Methods and compositions for modulating alpha adrenergic receptor activity
#902Bacterial efflux pump inhibitors for the treatment of ophthalmic and otic infections
#903Compositions and methods for treating or preventing inflammatory diseases
#904Methods and compositions for treating proliferative diseases
#905Antifungal compositions and method
#906Tetradydro-Naphthalene And Urea Derivatives
#907Enzymatic debridement therapy for abnormal cell proliferation
#908Methods and compositions for the treatment of neurodegenerative disorders
#909MN/CA IX and MAPK inhibition
#910Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinease Inhibitors
#911Reversible inhibition of sperm receptor synthesis for contraception
#912ω-carboxyl aryl substituted diphenyl ureas as p38 kinase inhibitors
#913Prodrug antibiotic screens
#914ANTAGONISTS OF ENDOTHELIAL DIFFERENTIATION GENE SUBFAMILY 3 (EDG-3, S1P3) RECEPTORS FOR PREVENTION AND TREATMENT OF OCULAR DISORDERS
#915Arylalkyl Ureas As Cb1 Antagonists
#916Diphenylurea Derivatives Useful As Potassium Channel Activators
#917Topical compositions of urea and ammonium lactate
#918Thiourea Derivative-Containing Pharmaceutical Composition Having Improved Solubility and Bioavailability
#919Peracetic teat dip
#920Dermatological composition containing alkyl ureas
#921Synergistic Mixtures of O-Phenylphenol and Dazomet
#922Preparing solid formulation of nanoparticles of pharmaceutical ingredient, including at least micron-sized particles
#923Active oxygen scavenging composition including citrulline
#924Methods for slowing senescence and treating and preventiing diseases associated with senescence
#925Topical Pharmaceutical Foam Composition
#926TRANSFERRIN AND TRANSFERRIN-BASED COMPOSITIONS FOR DIABETES TREATMENT
#927Therapeutic inhibitor of vascular smooth muscle cells
#928Use of peroxisome proliferator-activated receptor gamma (ppary) and/or retinoic acid receptor (rxr) agonists to inhibit platelet functions
#929Therapeutic inhibitor of vascular smooth muscle cells
#930Methods and compositions for altering cell function
#931Inhibitors of epoxide hydrolases for the treatment of inflammation
#932Methods and compositions for treating proliferative diseases
#933Treatment of ophthalmic disorders using urea and urea derivatives
#934OPHTHALMIC AND CONTACT LENS SOLUTIONS WITH A PEROXIDE SOURCE AND A PRESERVATIVE
#935SKIN CARE PRODUCTS
#936Pharmaceutical compositions for headache, migraine, nausea and emesis
#937Methods of modulating intestinal fluid balance
#938Phenol derivatives and their use as rotamase inhibitors
#939Inhibitors of 2-oxoglutarate dioxygenase as gamma globin inducers
#940Therapeutic compositions
#941Phosphate transport inhibitors
#942Urea compounds that promote desquamation
#943Use of hydroxylated amino acids for treating diabetes
#944ERG channel openers for the treatment of cardiac arrhythmias
#945Methods of increasing proliferation of adult mammalian cardiomyocytes through p38 map kinase inhibition
#946Treatment method for anemia
#947Methods for treating brain swelling with a compound that blocks a non-selective cation channel
#948Stabilization of hypoxia inducible factor (HIF) alpha
#949Dermatological compositions
#950Novel thiocarbamic acid derivatives and the pharmaceutical compositions containing the same
#951Combinations and modes of administration of therapeutic agents and combination therapy
#952Stabilization of hypoxia inducible factor (HIF) alpha
#953Stabilization of hypoxia inducible factor (HIF) alpha
#954Methods and composition for derepressions of IAP-inhibited caspase
#955Method of reducing drug-induced adverse side effects in a patient
#956Antibiotics targeting MreB
#957Compounds, compositions, and methods
#958Palatable ductile chewable veterinary composition
#959Combination comprising a vasculostatic compound and an alkylating agent for the treatment of a tumor
#960Formulations with anti-tumour action
#961Liquid, aqueous pharmaceutical compositions of factor VII polypeptides
#962Combinations for the treatment of diseases involving angiogenesis
#963Methods of increasing endogenous erythropoietin (EPO)
#964Method of treating autoimmune diseases
#965Use of inhibitors of soluble epoxide hydrolase to synergize activity of COX and 5-LOX inhibitors
#966Methods of increasing endogenous erythropoietin (EPO)
#967Methods of increasing endogenous erythropoietin (EPO)
#968Modulation of NMDA receptor currents via orexin receptor and/or CRF receptor
#969Peracetic teat dip
#970Method for extracting a novel compound from the root of a plant of the pentadiplandraceae family and use of N,N'-dibenzylthiourea as a medicine
#971Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease
#972Treatment of glioblastoma with thymosin-alpha 1
#973Compositions for delivery of drug combinations
#974Use of rapamycin and structural analogues thereof
#975Procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis
#976Compositions for down-regulation of CCR5 expression and methods of use thereof
#977Treatment of amm
#978Use of cis-epoxyeicosantrienoic acids and inhibitors of soluble epoxide hydrolase to reduce damage from stroke
#979Methods for treating and preventing brain cancers
#980Methods of modulating the activities of alpha-7 nicotinic acetylcholine receptor
#981Medicine comprising a thiourea for use as depigmenting agent or anti-mutagenic and anti-carcinogenic agent
#982Methods of treating tumors
#983Treatment of refractory cancers using NA+/K+ ATPase inhibitors
#984Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases
#985Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues
#986Fluid application device and method
#987Medicament for treatment of diabetes
#988Antipruritic composition for external use on skin
#989Activators and inhibitors of protease activated receptor2 (PAR2) and methods of use
#990Formulations for the treatment of pain
#991Inhibitors against the activation of ap-1 and nfat
#992Use of beta-2 bronchodilator drugs
#993Opthalmic and contact lens solutions with a peroxide source and a cationic polymeric preservative
#994Composition and method for treating skin conditions
#995Combination of antidiabetic drugs
#996Procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis
#997Facially amphiphilic polymers and oligomers and uses thereof
#998Treatment of male sexual dysfunction
#999Remedies for neurodegenerative diseases
#1000Method of treating autoimmune diseases
#1001Immunodulatory compositions and methods of use thereof
#1002Use of 1-(2-chloroethyl)-1-nitroso-3-(2-hydroxyethyl)urea for treatment of pancreatic carcinomas, soft tissue sarcomas, testicular tumors, lymphomas, thymomas, wilms' tumors, renal carcinomas, melanomas, lung tumors, intracerebral metastases, tumors in the head and neck area and mammary carcinomas
#1003Pharmaceutical compositions with synchronized solubilizer release
#1004Composition
#1005Permeation enhancing compositions for anticholinergic agents
#1006Use of alkylureas for treating acne
#1007Method of inhibiting dihydrofolate reductase; screening assay for the identification of novel therapeutics and their cellular targets
#1008Pharmaceutical composition comprising a beta-3-adrenoceptor agonist and a serotonin and/or norepinephrine reuptake inhibitor
#1009Pharmaceutical composition comprising beta-3-adrenoceptor-agonists and antimuscarinic agents
#1010Beta-tubulin inhibitors
#1011Compositions and methods for treating or preventing inflammatory diseases
#1012Methods and compositions for preventing or treating periodontal diseases
#1013Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
#1014Use of cis-Epoxyeicosantrienoic acids and inhibitors of soluble epoxide hydrolase to reduce pulmonary infiltration by neutrophils
#1015Selective inhibitors of the urokinase plasminogen activator
#1016N-aryloxypropanolyl-N′-phenethyl-urea
#1017Therapeutic uses for nitric oxide inhibitors
#1018Methods for treating Parkinson's disease
#1019Method of preparing intermediates useful in synthesis of retroviral protease inhibitors
#1020Pharmaceutically active aromatic guanylhydrazones
#1021Compounds, in particularly of urea derivatives or esters of haloacetamidobenzoic acid and use thereof for the treatment of parasitic diseases
#1022Immunomodulatory compounds and methods of use thereof
#1023Synthetic urine and method of manufacturing same
#1024Compounds, compositions and methods
#1025Coated drug delivery formulations
#1026Inhibitors of melanocyte tyrosinase as topical skin lighteners
#1027Use of cooling agents to relieve mild ocular irritation and enhance comfort
#1028Agents for intravitreal administration to treat or prevent disorders of the eye
#1029Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
#1030Method of treating atherosclerosis and hypercholesterolemia
#1031Immunomodulatory compounds and methods of use thereof
#1032Methods of treating conditions associated with an EDG-4 receptor
#1033Compositions and methods for treating or preventing hearing impairment
#1034Methods of treating conditions associated with an EDG-2 receptor
#1035Dermatological compositions
#1036Pharmaceutical compositions with synchronized solubilizer release
#1037Pharmaceutical compositions with synchronized solubilizer release
#1038Method for decreasing sebum production
#1039Active oxygen scavenging composition including citrulline
#1040Penetrating pharmaceutical foam
#1041Compositions comprising inhibitors of IMPDH enzyme
#1042Methods of using Flt3-Ligand in hematopoietic cell transplantation procedures incorporating nonmyeloablative conditioning regimens
#1043Topical compositions of urea
#1044Drug for preventing vascular restenosis and instrument to be embedded in vessel coated with the drug
#1045Topical compositions of urea and ammonium lactate
#1046Topical compositions of ammonium lactate
#1047Enhanced erythropoiesis and iron metabolism
#1048Method for treating perinatal asphyxia in a human or animal neonate
#1049Method of treating actinic keratosis
#1050Bis urea-based organoselenium compound and method for treating cancer
#1051Organoselenium compound for treating cancer
#1052Tablet for oral suspension
#1053Method for topical treatment of nail conditions
#1054Method for treating fungal infections in nails
#1055Slow release formulations of cell cycle regulators and anti-cancer agents for local treatment of solid cancer
#1056High-affinity small molecule formylpeptide receptor ligands from screening of combinatorial mixture-based libraries